REXAHN PHARMACEUTICALS INC (RNN) Stock Price & Overview
NYSEARCA:RNN
Current stock price
The current stock price of RNN is 5.24 null. Today RNN is up by 0.19%. In the past month the price decreased by -10.27%. In the past year, price decreased by -76.52%.
RNN Key Statistics
- Market Cap
- 21.06M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -3.53
- Dividend Yield
- N/A
RNN Stock Performance
RNN Stock Chart
RNN Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to RNN. When comparing the yearly performance of all stocks, RNN is a bad performer in the overall market: 95.42% of all stocks are doing better.
RNN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RNN. The financial health of RNN is average, but there are quite some concerns on its profitability.
RNN Earnings
RNN Forecast & Estimates
RNN Financial Highlights
Over the last trailing twelve months RNN reported a non-GAAP Earnings per Share(EPS) of -3.53. The EPS decreased by -498.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -75.35% | ||
| ROE | -91.82% | ||
| Debt/Equity | 0.01 |
RNN Ownership
About RNN
Company Profile
REXAHN PHARMACTICALS is a biopharmaceutical company leveraging its proprietary technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy.
Company Info
REXAHN PHARMACEUTICALS INC
15245 SHADY GROVE ROAD SUITE 455
ROCKVILLE MD 20850
CEO: Douglas J. Swirsky
Phone: 240-268-5300
REXAHN PHARMACEUTICALS INC / RNN FAQ
What does REXAHN PHARMACEUTICALS INC do?
REXAHN PHARMACTICALS is a biopharmaceutical company leveraging its proprietary technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy.
What is the stock price of REXAHN PHARMACEUTICALS INC today?
The current stock price of RNN is 5.24 null. The price increased by 0.19% in the last trading session.
Does RNN stock pay dividends?
RNN does not pay a dividend.
What is the ChartMill technical and fundamental rating of RNN stock?
RNN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Would investing in REXAHN PHARMACEUTICALS INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on RNN.
What is REXAHN PHARMACEUTICALS INC worth?
REXAHN PHARMACEUTICALS INC (RNN) has a market capitalization of 21.06M null. This makes RNN a Nano Cap stock.